Leadership

  • Donald A. Deieso, PhD

    Executive Chairman & Chief Executive Officer (CEO)
    full bio
  • Nicholas Slack, MBE

    Executive Vice President & Chief Commercial Officer
    full bio
  • Laurie L. Jackson, CPA, MBA

    Chief Financial Officer
    full bio
  • Christina Armstrong, RN

    Senior Vice President, Business Development
    full bio
  • Marco Capasso, JD

    Chief Legal Officer
    full bio
  • Jeffrey S. Litwin, MD

    Chief Operating Officer, WCG Clinical Services
    full bio
  • Jonathan Seltzer, MD, MBA, MA, FACC

    Chief Scientific Officer, WCG ACI Clinical
    full bio
  • Lindsay McNair, MD, MPH, MSB

    Chief Medical Officer
    full bio
  • Ian Neilson

    Chief Information Officer
    full bio
  • Emmanuel Olart, MS

    Chief Application Officer
    full bio
  • Dawn Flitcraft

    Chief M&A Integration Officer
    full bio
  • Craig Sowell, MA

    Chief Marketing Officer
    full bio
  • April Mulroney

    Senior Vice President & Chief Data Officer
    full bio
  • Meghan Weiss, M Ed

    Senior Vice President, Human Capital Management
    full bio
  • Stephen M. McLean, Jr.

    Treasurer & Vice President, Corporate Development
    full bio
  • Jill Johnston

    President, Site Activation
    full bio
  • Mark Summers

    President, Patient Engagement
    full bio
  • James A. Bannon, PharmD

    President, Scientific & Regulatory Review
    full bio
  • Cynthia Carter, BA

    President, Market Insights
    full bio
  • Stuart Horowitz, PhD, MBA

    President, Institutions & Institutional Services
    full bio
  • Jonathan Zung, Ph.D.

    President, Clintrax and Advisor to CEO WCG
    full bio
  • Donald A. Deieso, PhD

    Executive Chairman & Chief Executive Officer (CEO)
    full bio
  • Gene Gorbach, MBA

    Vice President, Arsenal Capital Partners
  • James Rothman, PhD

    Yale University; Recipient, Nobel Prize in Medicine, 2013
  • Jeffrey Kovach

    CO-CHIEF INVESTMENT OFFICER, ARSENAL CAPITAL PARTNERS
  • Kenneth A. Getz, MBA

    Founder, CenterWatch; Chairman, CISCRP; Associate Professor, Tufts Center for the Study of Drug Development
  • Per Peterson, PhD

    Director, Life Technologies
  • Shamit Grover

    Managing Director, Private Capital Group, MSD Partners; Board of Directors, Waypoint Leasing Holdings
  • Sir William Castell

    SENIOR ADVISOR, ARSENAL CAPITAL PARTNERS; PREVIOUSLY PRESIDENT & CHIEF EXECUTIVE OFFICER, GE HEALTHCARE
  • Stephen McLean, MBA

    Partner & Co-Head Healthcare Group, Arsenal Capital Partners; Founding Partner, Merrill Lynch Capital Partners, Inc. (and successors)
  • Arthur L. Caplan, PhD

    Drs. William F. and Virginia Connolly Mitty Professor & Head, Division of Bioethics, New York University Langone Medical Center
  • James A. Bannon, PharmD

    President, Scientific & Regulatory Review
    full bio
  • Jeremy Katz

    Founder & Former President, Research Dataware, LLC (IRBNet)
  • Peter Tong

    Chairman, Obagi Medical Products, Inc. (OMP) and Board of Directors, Packard BioScience Company
  • Scott Hayworth, MD

    President & Chief Executive Officer, Mount Kisco Medical Group (MKMG)
  • Amit Bhattacharyya, PhD

    Vice President, Biometrics, WCG ACI Clinical
    full bio
  • Brooke Millman, JD

    Vice President Consulting Solutions, Site Contracting & Payments
    full bio
  • Christopher Randolph, PhD, ABPP-CN

    Chief Scientific Officer, WCG MedAvante-ProPhase
    full bio
  • Currien MacDonald, MD, CIP

    IRB Chair, WIRB
    full bio
  • Daniel Kavanagh, PhD

    Senior Scientific Advisor, Gene Therapy
    full bio
  • David A. Borasky Jr., MPH, CIP

    Vice President, IRB Compliance
    full bio
  • David Forster, JD, MA, CIP

    Chief Compliance Officer
    full bio
  • Jeffrey A. Cooper, MD, MMM

    Vice President, Process & Strategic Improvement
    full bio
  • Jill Johnston

    President, Site Activation
    full bio
  • Jonathan Seltzer, MD, MBA, MA, FACC

    Chief Scientific Officer, WCG ACI Clinical
    full bio
  • Linda B. Sullivan, MBA

    Metrics Champion Consortium Co-Founder & Executive Director
    full bio
  • Lindsay McNair, MD, MPH, MSB

    Chief Medical Officer
    full bio
  • Mark G. A. Opler, PhD, MPH

    Chief Research Officer, WCG MedAvante-ProPhase
    full bio
  • Nicholas Slack, MBE

    Executive Vice President & Chief Commercial Officer
    full bio
  • Sofija Jovic, PhD, MBA

    Business Transformation Advisor
    full bio
  • Stuart Horowitz, PhD, MBA

    President, Institutions & Institutional Services
    full bio
  • Sue Vallow

    Vice President, eCOA Solutions, WCG MedAvante-Prophase
    full bio
  • Suzanne Caruso

    Vice President, Clinical Solutions
    full bio

The WCG Oncology Advisory Board is made up of thought-leaders in oncology who provide WCG with guidance and strategic counsel on the changing landscape of research in oncology.

  • Amy B. Heimberger, MD

    Professor, Department of Neurosurgery, MD Anderson Cancer Center
  • Arnold J. Levine, PhD

    Professor Emeritus, Institute for Advanced Study, School of Natural Sciences
  • George Demetri, MD

    Dana-Farber Cancer Institute
  • Howard Scher, MD

    Memorial Sloan Kettering Cancer Center
  • James Rothman, PhD

    Yale University; Recipient, Nobel Prize in Medicine, 2013
  • John E. Neiderhuber, MD

    Inova Translational Medicine Institute; Former Head of the National Cancer Institute

The WCG Gene Therapy Advisory Board provides guidance and strategic counsel to WCG and our clients, ensuring that knowledge and best practices are reflected in the company’s oversight of human gene transfer research, which involves the careful coordination of institutional review board (IRB) and institutional biosafety committee (IBC) reviews.

  • Arnold J. Levine, PhD

    Professor Emeritus, Institute for Advanced Study, School of Natural Sciences
  • Carl June, MD

    Richard W. Vague Professor In Immunotherapy, University of Pennsylvania
  • Hans-Peter Kiem, MD, Dr. MED

    Endowed Chair for Cell and Gene Therapy, Fred Hutch; Professor of Medicine, University of Washington
  • Mark Bagarazzi, MD

    Chief Medical Officer, Inovio Pharmaceuticals
  • Tony Reid, MD, PhD

    Professor of Medicine, University of California, San Diego

The CNS Scientific Leadership Team reflects multiple specialties within the therapeutic area of central nervous system (CNS). The specialists provide expert guidance to WCG’s clients, while also supporting the design and execution of WCG’s technology-enabled solutions applied to clinical trials in neurodegenerative and behavioral health disorders.

  • Andrew J. Cutler, MD

    Expertise: Non-Alzheimer’s Disease Dementias and Neurobehavior
    full bio
  • Christoph Correll, MD

    Expertise: Child and Adolescent Psychiatry
    full bio
  • James E. Galvin, MD, MPH

    Expertise: Non-Alzheimer’s Disease Dementias and Neurobehavior
    full bio
  • Leo Verhagen Metman, MD, PhD

    Expertise: Parkinson’s Disease
    full bio
  • Leslie Citrome, MD, MPH

    Expertise: Schizophrenia and Psychosis
    full bio
  • Michael R. Liebowitz, MD

    Expertise: Social Anxiety Disorders
    full bio
  • Philip Scheltens, MD, PhD

    Expertise: Alzheimer’s Disease
    full bio
  • Scott J. Hunter, PhD

    Expertise: Neurodevelopment, Autism and Rare & Orphan Disorders
    full bio